Bayer AG has teamed up with medical dermatology company Azitra Inc. to develop consumer health products that harness the skin microbiome to treat conditions such as atopic dermatitis.
The firms have signed a joint development agreement to identify potential candidates for the treatment of adverse skin conditions and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?